Literature DB >> 22161683

Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts.

Leigh Zerboni1, Ann Arvin.   

Abstract

Varicella-zoster virus (VZV) is a medically important human alphaherpesvirus. Investigating pathogenic mechanisms that contribute to VZV neurovirulence are made difficult by a marked host restriction. Our approach to investigating VZV neurotropism and neurovirulence has been to develop a mouse-human xenograft model in which human dorsal root ganglia (DRG) are maintained in severe compromised immunodeficient (SCID) mice. In this review, we will describe our key findings using this model in which we have demonstrated that VZV infection of SCID DRG xenograft results in rapid and efficient spread, enabled by satellite cell infection and polykaryon formation, which facilitates robust viral replication and release of infectious virus. In neurons that persist following this acute replicative phase, VZV genomes are present at low frequency with limited gene transcription and no protein synthesis, a state that resembles VZV latency in the natural human host. VZV glycoprotein I and interaction between glycoprotein I and glycoprotein E are critical for neurovirulence. Our work demonstrates that the DRG model can reveal characteristics about VZV replication and long-term persistence of latent VZV genomes in human neuronal tissues, in vivo, in an experimental system that may contribute to our knowledge of VZV neuropathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22161683     DOI: 10.1007/s13365-011-0066-x

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   3.739


  39 in total

1.  Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection.

Authors:  Barbara Berarducci; Minako Ikoma; Shaye Stamatis; Marvin Sommer; Charles Grose; Ann M Arvin
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 2.  Specification and connectivity of neuronal subtypes in the sensory lineage.

Authors:  Frédéric Marmigère; Patrik Ernfors
Journal:  Nat Rev Neurosci       Date:  2007-02       Impact factor: 34.870

3.  Latency of alpha-herpes viruses is accompanied by a chronic inflammation in human trigeminal ganglia but not in dorsal root ganglia.

Authors:  Katharina Hüfner; Tobias Derfuss; Simone Herberger; Kishiko Sunami; Steven Russell; Inga Sinicina; Viktor Arbusow; Michael Strupp; Thomas Brandt; Diethilde Theil
Journal:  J Neuropathol Exp Neurol       Date:  2006-10       Impact factor: 3.685

4.  Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis.

Authors:  Leigh Zerboni; Barbara Berarducci; Jaya Rajamani; Carol D Jones; James L Zehnder; Ann Arvin
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

5.  Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons.

Authors:  R Mahalingam; M Wellish; R Cohrs; S Debrus; J Piette; B Rentier; D H Gilden
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

6.  Emergence of the sensory nervous system as defined by Foxs1 expression.

Authors:  Andreas Montelius; Frédéric Marmigère; Christel Baudet; Jorge B Aquino; Sven Enerbäck; Patrik Ernfors
Journal:  Differentiation       Date:  2007-02-16       Impact factor: 3.880

7.  Translation of varicella-zoster virus genes during human ganglionic latency.

Authors:  Esther Grinfeld; Peter G E Kennedy
Journal:  Virus Genes       Date:  2004-12       Impact factor: 2.332

8.  Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts.

Authors:  Stefan L Oliver; Leigh Zerboni; Marvin Sommer; Jaya Rajamani; Ann M Arvin
Journal:  J Virol Methods       Date:  2008-09-24       Impact factor: 2.014

9.  Aberrant intracellular localization of Varicella-Zoster virus regulatory proteins during latency.

Authors:  O Lungu; C A Panagiotidis; P W Annunziato; A A Gershon; S J Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

10.  Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I.

Authors:  Leigh Zerboni; Mike Reichelt; Carol D Jones; James L Zehnder; Hideki Ito; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-20       Impact factor: 11.205

View more
  10 in total

1.  Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis.

Authors:  Stefan L Oliver; Edward Yang; Ann M Arvin
Journal:  Curr Clin Microbiol Rep       Date:  2016-09-09

Review 2.  Varicella zoster virus vaccines: potential complications and possible improvements.

Authors:  Benjamin Silver; Hua Zhu
Journal:  Virol Sin       Date:  2014-10-24       Impact factor: 4.327

3.  Nectin-1 Is an Entry Mediator for Varicella-Zoster Virus Infection of Human Neurons.

Authors:  Labchan Rajbhandari; Priya Shukla; Balaji Jagdish; Abby Mandalla; Qingxue Li; Mir A Ali; Hojae Lee; Gabsang Lee; Tomohiko Sadaoka; Jeffrey I Cohen; Arun Venkatesan
Journal:  J Virol       Date:  2021-09-01       Impact factor: 5.103

4.  A bright future for bioluminescent imaging in viral research.

Authors:  Stewart M Coleman; Alistair McGregor
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

5.  Productive vs non-productive infection by cell-free varicella zoster virus of human neurons derived from embryonic stem cells is dependent upon infectious viral dose.

Authors:  Anna Sloutskin; Paul R Kinchington; Ronald S Goldstein
Journal:  Virology       Date:  2013-06-12       Impact factor: 3.616

6.  An in vitro model of latency and reactivation of varicella zoster virus in human stem cell-derived neurons.

Authors:  Amos Markus; Ilana Lebenthal-Loinger; In Hong Yang; Paul R Kinchington; Ronald S Goldstein
Journal:  PLoS Pathog       Date:  2015-06-04       Impact factor: 6.823

7.  Strategies in gene therapy for glioblastoma.

Authors:  Aneta Kwiatkowska; Mohan S Nandhu; Prajna Behera; E Antonio Chiocca; Mariano S Viapiano
Journal:  Cancers (Basel)       Date:  2013-10-23       Impact factor: 6.639

8.  Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.

Authors:  Andrea Harrer; Peter Wipfler; Georg Pilz; Katrin Oppermann; Elisabeth Haschke-Becher; Shahrzad Afazel; Jörg Kraus; Eugen Trinka; Johann Sellner
Journal:  Int J Mol Sci       Date:  2015-09-10       Impact factor: 5.923

Review 9.  Modeling Varicella Zoster Virus Persistence and Reactivation - Closer to Resolving a Perplexing Persistent State.

Authors:  Lillian Laemmle; Ronald S Goldstein; Paul R Kinchington
Journal:  Front Microbiol       Date:  2019-07-24       Impact factor: 5.640

Review 10.  Current In Vivo Models of Varicella-Zoster Virus Neurotropism.

Authors:  Ravi Mahalingam; Anne Gershon; Michael Gershon; Jeffrey I Cohen; Ann Arvin; Leigh Zerboni; Hua Zhu; Wayne Gray; Ilhem Messaoudi; Vicki Traina-Dorge
Journal:  Viruses       Date:  2019-05-31       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.